Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5793 record(s)

Req # A-2023-001174

The approved labelling for the products BD ONCLARITY HPV ASSAY and BD ONCLARITY HPV ASSAY REAGENT PACK authorized under Licence No. 99811.

Organization: Health Canada

96 page(s)
April 2024

Req # A-2023-001209

Newest Abbreviated New Drug Submission (ANDS) for liraglutide, the ANDS cover letter of the company who submitted the Second Liraglutide ANDS.

Organization: Health Canada

2 page(s)
April 2024

Req # A-2023-001299

The most recent Certified Product Information Document (CPID) submitted for the Estradiol Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

19 page(s)
April 2024

Req # A-2023-001436

Application form for Artron's COVID-19 Antigen Test - IO 327866.

Organization: Health Canada

5 page(s)
April 2024

Req # A-2023-001565

Studies suggesting that transgender people face substantial barriers to abortion services.

Organization: Health Canada

28 page(s)
April 2024

Req # A-2023-001593

The statements made by federal Health Minister Mark Holland to the media on March 20, 2024. The email or letter correspondence referenced by Mr. Holland, which was stated to have been sent to the provincial and territorial health ministries in relation to the regulation, advertising and sale of nicotine replacement therapy and/or buccal nicotine pouch products. Timeframe of the request: March 11, 2024 - March 25, 2024.

Organization: Health Canada

5 page(s)
April 2024

Req # A-2020-001030

Adverse Drug Reactions (ADRs). Report numbers: 000721620, 000721621, 000721623, 000721654, 000721705, 000721791, 000721858, 000721859, 000722031, 000722048, 000722071, 000722086, 000722112, 000722119, 000722122, 000722123, 000722145, 000722159, 000722166, 000722199.

Organization: Health Canada

315 page(s)
April 2024

Req # A-2020-001430

Adverse Drug Reactions (ADRs). Report numbers: E2B_02959763, E2B_02959832, E2B_02959837, E2B_02960718, E2B_02961718, E2B_02961975, E2B_02962182, E2B_02962222, E2B_02962228, E2B_02962240, E2B_02962267, E2B_02962383, E2B_02962725, E2B_02962736, E2B_02962739, E2B_02962741, E2B_02962742, E2B_02962746, E2B_02962752, E2B_02962762.

Organization: Health Canada

267 page(s)
April 2024

Req # A-2020-001535

Adverse Drug Reactions (ADRs). Report numbers: E2B_03106484, E2B_03107034, E2B_03107273, E2B_03107558, E2B_03107824, E2B_03108501, E2B_03109625, E2B_03110378, E2B_03110399, E2B_03110511, E2B_03110611, E2B_03110675, E2B_03111060, E2B_03111289, E2B_03111329, E2B_03111356, E2B_03111361, E2B_03111425, E2B_03111555, E2B_03111769.

Organization: Health Canada

418 page(s)
April 2024

Req # A-2020-001610

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114416-734.

Organization: Health Canada

24 page(s)
April 2024
Date modified: